Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 24 (August 20), 2008: pp. 4045
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.18.2634

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neugut, A. I.
Right arrow Articles by Hershman, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Neugut, A. I.
Right arrow Articles by Hershman, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

In Reply

Alfred I. Neugut, Judith S. Jacobson, Dawn Hershman

Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

We appreciate the comments by De Giorgi et al regarding our recent publication in Journal of Clinical Oncology.1 We do not disagree with their fundamental point. By nature, reports of the long-term sequelae of an intervention, whether based on randomized trials or observational studies, are often outdated by the time of publication due to advances or changes in technology. The patients in our study were diagnosed between the years 1965 and 1985 and had a minimum follow-up of 10 years. We undertook our study with the understanding that changes in radiotherapy techniques occurring in the intervening decades might lead to changes in treatment-related risks.

We do have some minor corrections. Our study was not a pilot study. We had previously conducted a pilot study2 using more crude data and methods, but with similar findings. We consider the current study to be complete.

Regarding screening, we are aware that a randomized trial for proof of efficacy of computed tomography scanning for lung cancer has not yet been completed, but allowances are often made in high-risk situations. Given the risks described in our article, smokers who have received radiotherapy for breast cancer more than 10 years ago may qualify for such allowances.

Finally, we concur that an adverse effect should not be considered a reason to avoid a beneficial treatment. However, as we stated in the article, the benefit of postmastectomy radiotherapy (PMRT) in borderline settings may need to be weighed against such risks. Yu et al3 showed that even with large tumors, patients with node-negative disease may not benefit from PMRT, and other studies show that significant numbers of patients with small node-negative tumors receive PMRT despite the probable absence of benefit.4 In settings where the use of PMRT is questionable, particularly when the patient is a smoker, the physician and patient need to weigh more carefully the relative risks and benefits of its use.

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The author(s) indicated no potential conflicts of interest.

REFERENCES

1. Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 26:392-398, 2008[Abstract/Free Full Text]

2. Neugut AI, Murray T, Santos J, et al: Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73:1615-1620, 1994[CrossRef][Medline]

3. Yu JB, Wilson LD, Dasgupta T, et al: Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: Analysis of the NCI Surveillance, Epidemiology, and End Results database. Cancer 113:38-47, 2008[CrossRef][Medline]

4. Smith BD, Haffty BG, Hurria A, et al: Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24:4901-4907, 2006[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neugut, A. I.
Right arrow Articles by Hershman, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Neugut, A. I.
Right arrow Articles by Hershman, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online